• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma

    2022-10-08 05:42:36AlessandroSerafiniValeriaRuggeriRiccardoInchingoloMarcoGattiAlessiaGuarneriCesareMainoDavideIppolitoLuigiGrazioliUmbertoRicardiRiccardoFaletti
    World Journal of Hepatology 2022年9期

    Alessandro Serafini, Valeria Ruggeri, Riccardo Inchingolo, Marco Gatti, Alessia Guarneri, Cesare Maino,Davide Ippolito, Luigi Grazioli, Umberto Ricardi, Riccardo Faletti

    Alessandro Serafini, Marco Gatti, Riccardo Faletti, Department of Surgical Sciences, University of Turin, Turin 10126, Italy

    Valeria Ruggeri, Department of Radiology, University of Brescia, Brescia 25123, Italy

    Riccardo lnchingolo, Interventional Radiology Unit, Miulli Hospital, Acquaviva Delle Fonti 70124, Italy

    Alessia Guarneri, Umberto Ricardi, Department of Oncology-Radiation Oncology, University of Turin, Turin 10126, Italy

    Cesare Maino, Davide lppolito, Department of Diagnostic Radiology, University of Milano-Bicocca, Monza 20900, Italy

    Luigi Grazioli, Department of Radiology, Spedali Civili, University of Brescia, Brescia 25023, Italy

    Abstract BACKGROUND Although stereotactic body radiation therapy (SBRT) is increasingly used, its application has not yet been regulated by the main international guidelines, leaving the decision to multidisciplinary teams.AIM To assess magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) treated with SBRT, highlighting the efficacy of the treatment and the main aspects of the lesion before and after the procedure.METHODS As part of a retrospective study, 49 patients who underwent SBRT for HCC between January 2013 and November 2019 were recruited. Each patient underwent a pre-treatment MRI examination with a hepatospecific contrast agent and a similar followup examination within 6 mo of therapy. In addition, 22 patients underwent a second follow-up examination after the first 6 mo. The following characteristics were analysed: Features analysed compared to pre-treatment MRI examination, presence or absence of infield and outfield progression, ring-like enhancement, signal hyperintensity in T2-weighted sequences in the perilesional parenchyma, capsular retraction, and "band" signal hypointensity in T1-weighted gradient echo fat saturated sequences obtained during hepatobiliary excretion.RESULTS Signal hyperintensity in the T2-weighted sequences showed a statistically significant reduction in the number of lesions at the post-SBRT first control (P = 0.0006). Signal hyperintensity in diffusionweighted imaging-weighted sequences was decreased at MRI first control (P < 0.0001). A statistically significant increase of apparent diffusion coefficient values from a median of 1.01 to 1.38 at the first post-control was found (P < 0.0001). Capsular retraction was increased at the late evaluation (P = 0.006). Band-like signal hypointensity in the hepatobiliary phase was present in 94% at the late control (P = 0.006). The study of the risk of outfield progression vs infield progression revealed a hazard ratio of 9.CONCLUSION The efficacy of SBRT should be evaluated not in the first 6 mo, but at least 9 mo post-SBRT, when infield progression persists at very low rates while the risk of outfield progression increases significantly.

    Key Words: Hepatocellular carcinoma; Stereotactic body radiation therapy; Magnetic resonance imaging; Histopatology; Outcome; Radiology

    lNTRODUCTlON

    Although stereotactic body radiation therapy (SBRT) is increasingly used, its application has not yet been regulated by the main international guidelines, leaving the decision to multidisciplinary teams. Lack of diffusion and standardization of treatment indications makes the radiological definition of outcome particularly complex and not completely concordant with the main therapy evaluation systems (modified Response Evaluation Criteria in Solid Tumors [mRECIST] and European Association for the Study of the Liver [EASL]). By analysing the magnetic resonance imaging (MRI) semeiological characteristics of the hepatocellular carcinoma (HCC) lesions treated by SBRT and the remaining liver parenchyma, it would be possible to evaluate further evolution over time and changes in the diagnostic process following therapy[1].

    In addition, search of possible correlations between MRI findings and clinical, laboratory, and radiotherapy data could help to prevent radio-induced liver damage and to implement customized treatment planning. This has made it possible to use this treatment in different stages of HCC, both in patients with early-stage unifocal disease and in patients not eligible for other loco-regional therapies and for palliative purposes[2,3].

    From a technical point of view, the number of target lesions as well as their location within the liver are potential limitations in treatment planning and dose distribution. A minimum distance of at least 5 mm of the target HCCs from adjacent hollow viscera is recommended, otherwise the dose has to be reduced to match tolerance of neighboring organs.

    Semeiotic characteristics of SBRT-treated lesions differ from the imaging of other locoregional therapies: Whereas the latter results in immediate devascularization of tumor, radiotherapy leads to histological changes in the lesion and surrounding parenchyma that are gradual over time. Reflecting evolution of histological changes, an acute, subacute, or chronic stage can also be distinguished[4-10].

    The main aim of the study was to analyse MRI features of HCC lesions treated by SBRT and the remaining liver parenchyma, to monitor how these properties evolve over time and how these aspects may modify subsequent diagnostic course of therapy.

    MATERlALS AND METHODS

    Patient population

    A retrospective observational study was conducted in 49 patients (mean age 64.44 years, range 48.71-84.51), 22 females and 27 males, undergoing radiotherapy between January 2013 and November 2019.

    In 29 (59%) patients, SBRT was chosen as the first treatment option, and in 20 (41%) patients, it was in combination with previous locoregional treatments on the same lesion. Six (12%) of these patients subsequently underwent liver transplantation (bridge therapy).

    Sixty-one lesions were treated; among those, 42 were newly diagnosed HCCs and 19 were focal lesions that had already undergone previous treatment and were therefore attributable to persistent or recurrent disease.

    In the period between January 2013 and June 2020, each patient underwent an MRI examination with a hepatospecific contrast agent prior to treatment, and a similar follow-up examination within 6 mo of therapy (mean time 4 mo). In addition, 22 patients (a total of 36 lesions) underwent a second follow-up after the first 6 mo (mean time 9 mo).

    Imaging protocol

    All MRI examinations were performed with 1.5 T equipment (Philips Achieva), with a hepatospecific contrast agent (Primovist 0.25 mmol/mL, Bayer Schering Pharma, Berlin, Germany) infused at a dose of 0.1 mL/kg with a flow rate of 2 mL/sec.

    Imaging analysis before treatment

    The acquired images were re-evaluated using the PACS system (Synapse PACS, Tokyo, Japan) by a radiologist with 15 years of experience in abdominal MRI.

    For each lesion, the following characteristics were analysed and catalogued: Newly diagnosed HCC or previously treated HCC (persistence or recurrence of disease); Liver segment; Centroparenchymal or subcapsular location (distance from glissonian surface ≤ 10 mm); Diameter of hypervascularised tissue in the arterial phase; Diameter of the lesion in basal (T1-weighted in-phase and out-of-phase) sequences; Diameter in hepatobiliary excretory phase sequences; Average lesion diameter; Presence or absence of signal hyperintensity in the T2-weighted sequences, in relation to the surrounding parenchyma; Presence or absence of signal enhancement on diffusion-weighted imaging (DWI); and apparent diffusion coefficient (ADC) value (obtained by manually positioned region of interest [ROI]).

    Radiotherapeutic data analysis

    All lesions that did not show an increase in size or contrast-enhancement intensity in the arterial phase were considered free of progressing disease, and therefore treatment was assessed as effective. Tumor staging was performed according to the BCLC system. Pre-treatment Child-Pugh score, pretreatment ALBI, occurrence of RILD, Child-Pugh score variation after treatment, ALBI change after treatment, total liver volume, and planning target volume (PTV) were also assessed.

    Imaging analysis after treatment

    The following features were analysed in the post-treatment MRI examinations: Features analysed on pre-treatment MRI examination; Presence or absence of infield progression: Signs of disease progression within the treated field (increase in size and/or increase in intensity of arterial contrast-enhancement); Presence or absence of outfield progression: Signs of disease progression outside the radio-treated field according to mRECIST criteria; Presence or absence of ring-like enhancement (altered vascularity of the parenchyma adjacent to the treated lesion); Presence or absence of signal hyperintensity in T2-weighted sequences in the perilesional parenchyma; Presence or absence of capsular retraction; Presence or absence of "band" signal hypointensity in T1-weighted gradient echo fat saturated sequences obtained in the perilesional parenchyma; T1-weighted sequences obtained during hepatobiliary excretion of irradiated parenchyma; Calculation of the volume of "band" area in T1-weighted gradient echo fat saturated sequences acquired during hepatobiliary excretion by manual segmentation using polygonal ROIs, using the OsiriX DICOM Viewer software. A retrospective analysis was performed comparing pre-treatment MRI characteristics with subsequent follow-ups.

    RESULTS

    Almost 55.7% of the treated lesions had a subcapsular location; the distribution in the different hepatic segments was as follows: 3 in S1, 4 in S2, 2 in S3, 8 in S4, 10 in S5, 5 in S6, 9 in S7, and 20 in S8 (Figure 1-5).

    Figure 1 Change in lesion diameter. MR: Magnetic resonance.

    Figure 2 Tissue diameter with wash-in at pre-stereotactic body radiation therapy and follow-ups. MR: Magnetic resonance.

    Figure 3 Variation in lesion diameters over time in basal, arterial, and hepatobiliary excretion phases.

    Figure 4 Frequency of signal hyperintensity in T2-weighted and diffusion-weighted imaging sequences. MR: Magnetic resonance; DWI: Diffusion-weighted imaging.

    Figure 5 Apparent diffusion coefficient value at pre-stereotactic body radiation therapy and follow-ups. MR: Magnetic resonance; ADC: Apparent diffusion coefficient.

    The average diameter of the lesions was 17 mm (SD 13-24mm), a value that was significantly reduced both at the first control (10 mm, SD 11-20mm) and at the second follow-up (10 mm, SD 7-15mm) (Table 1).

    Five (8.2%) out of 61 lesions were hypovascular HCC. The remaining lesions showed typical postcontrast features with a mean diameter of 17 mm (range 12-24 mm), with a statistically significant reduction at follow-up (Figure 6).

    Figure 6 Comparison of changes in T2-weighted and diffusion-weighted imaging findings and apparent diffusion coefficient values over time. ADC: Apparent diffusion coefficient; DWI: Diffusion-weighted imaging; T2W: T2-weighted; SBRT: Stereotactic body radiation therapy.

    Both the diameter during the hepatobiliary phase and in basal T1 weighted sequences underwent a size reduction at both controls (Figure 7).

    Figure 7 Frequency of perilesional parenchyma findings. MR: Magnetic resonance; HBP: Hepatobiliary phase.

    On pre-treatment MRI, signal hyperintensity in the T2-weighted sequences was found in 62% of lesions, but it was only 30% at the post-SBRT first control, with a statistically significant reduction in the number of lesions (P= 0.0006).

    Signal hyperintensity in DWI-weighted sequences was found in 68% of lesions and in only 18% at MRI first control (P <0.0001). For both T2 and DWI variations, no statistically significant changes were found between first and second MRI controls (Figure 8).

    Figure 8 Risk of presenting infield and outfield progression over time.

    These variations were associated with a statistically significant increase of ADC values, which increased from a median of 1.01 at the pre-treatment examination to 1.38 at the first post-control (P <0.0001).

    In most of the lesions, the typical characteristics of the action of SBRT were identified. In particular, at the first MRI examination, 82% of the lesions showed ring-like enhancement and 84% perilesional hyperintensity in T2-weighted sequences. These percentages tended to decrease at the second MRI examination (69% and 75%, respectively) (Figure 9).

    Figure 9 lnfield and outfield progression and impact on survival.

    Capsular retraction was evident in 33% of cases at the first control, a features that significantly increased to 64% at the late evaluation (P= 0.006).

    Band-like signal hypointensity in the hepatobiliary phase was present at the first control in 95% of cases and in 94% at the late control (P= 0.006). The mean volume of the area of hypointensity calculated by manual segmentation was 85.47 cm3(range 15.21-248.16) (Figure 10).

    Figure 10 Relationship between hepatobiliary phase hypointensity area and planning target volume. HBP: Hepatobiliary phase.

    Considering the mRECIST criteria for evaluation of response to therapy, at the first examination signs of infield progression were observed in 5% of cases (3 lesions), while it was 18% for outfield progression signs (Figure 11).

    Figure 11 T2-weighted hyperintensity and diffusion-weighted imaging signal percentage at pre-stereotactic body radiation therapy and follow-ups. T2W: T2-weighted; DWI: Diffusion-weighted imaging.

    At the second MRI check-up, only one (3%) case of infield progression and 19 (28%) cases of outfield progression were observed (Figure 12).

    The study of the risk of outfield progressionvsinfield progression revealed a hazard ratio of 9.

    The risk increased as time progressed, with a sharp increase in the cumulative outfield progression hazard of around 9 after the end of therapy, as shown by the Kaplan-Meier-curve study (Figure 13).

    The time free from progression through the Kaplan-Meier curve showed a plateau of onset of infield progression around 9 mo, an interval in which outfield progression tended to increase.

    A direct relationship was also found between the area of band hypointensity during hepatobiliary excretion calculated by segmentation and PTV.

    The two volumes were linked by a parabolic correlation: Up to certain volumes of PTV, the area of hypointensity also increased in a directly proportional manner. For particularly high PTV values (greater than 300 cm3), the hepatic reaction area remained at significantly lower values.

    No further statistically significant correlations were found between the available clinical data, the radiotherapy data obtained, and the radiological findings.

    DlSCUSSlON

    In the acute stage (1-3 mo post-SBRT), typical peripheral hyperarterization can be seen, which persists or subsides in the subsequent post-contrast phases, referred to as ring-like enhancement. These changes imply the phenomena of venous congestion and reactive hyperemia in the treated area[10].

    In the subacute stage (3-6 mo post-SBRT), the parenchyma involved shows relative hypoattenuation in basal and portal acquisitions, with progressive enhancement in the late phase, related to the occlusion of the centrolobular veins and reduced intravenous contrast clearance[6].

    In the chronic stage (more than 6 mo after treatment), imaging will reveal changes caused by radioinduced fibrosis[6,11].

    Table 1 Magnetic resonance imaging characteristics at pre- and post- stereotactic body radiation therapy follow-ups

    The study showed the effectiveness of the treatment in controlling local disease, in particular, as already described in the literature, the reduction in the diameters of the lesion assessed (arterial, hepatobiliary, and basal sequences) also becomed increasingly marked at the controls following the first[5,6].

    This phenomenon is attributable to microscopic phenomena due to venocclusion that leads to fibrosis and collapse of the liver lobules at a late stage, and a reduced nutrient supply to the lesion and a progressive volumetric reduction of the whole radio-treated parenchyma[12,13].

    In addition to the analysis of the classical criteria for locoregional treatment, the study focused on the analysis of signal intensities in the T2- and DWI-weighted sequences. Both sequences provide information about the nature of the tissue and the cellularity of the lesion and are therefore useful "sentinel" parameters of treatment outcome.

    Signal hyperintensity both in the long TR and DWI sequences tended to decrease at the first control, remaining stable at subsequent controls, showing isointensisty to the surrounding liver parenchyma[6,10].

    There is a statistically significant increase in the ADC values measured before and after SBRT, probably due to a reduction in the cellularity of the lesions due to necrosis.

    As already described by Oldriniet al[10], persistence of arterial enhancement after stereotactic radiotherapy is common. In particular, arterial enhancement persisted in our population, but its diameter tended to decrease over time, probably due to progressive and slow necrosis and intralesional gigantocellular reaction. If this hypervascularisation, especially in a short-distance follow-up, was to be assessed in the same way as other locoregional therapies according to mRECIST criteria, it would be considered as a persistence of viable tissue and evaluated as ineffective[9,10]. This is in contradiction with what was reported in the literature, attesting to a percentage of complete response to SBRT that tends to progressively increase up to 90% at 12-24 mo after treatment, a figure confirmed by our study in which infield progression at the second control was 3%.

    Figure 12 Stereotactic body radiation therapy planning for hepatocellular carcinoma. A: Radiotherapy treatment planning with visualization of clinical target volume (pink line), planning target volume (red line), and areas of decreasing isodose; B: 3D rendering of the radiation beam and its incidence on the patient once positioned on the couch; C-E: Fusion Imaging of pre-stereotactic body radiation therapy planning (clinical target volume, pink line; planning target volume, red line; Isodose, 50% blue line) with magnetic resonance imaging images of the hepatobiliary excretion phase obtained 6 mo after the end of treatment. Band-like hypodensity during hepatobiliary excretion, an expression of functional resentment of the radio-treated parenchyma, is superimposed on the planning target volume area.

    For a correct interpretation of post-procedural imaging, it is essential to recognize features in the periinjury parenchyma and how they change over time: Peripheral hypervascularisation, signal hyperintensity in long TR sequences, and band hypointensity in the hepatobiliary excretion phase.

    In the context of computed tomography (CT), the imaging characteristics of focal hepatic reaction have been well described. In the immediate post-treatment, hyperdensity occurs in early vascular phase as a consequence of sinusoidal congestion and reduced venous drainage, which gradually subsides in the portal and late phases. This may make it difficult to distinguish any persistence of hypervascularised lesional tissue in the arterial phase.

    Over time, as fibrosis sets in, there will be contrastographic impregnation of the closely packed parenchyma closely contiguous to the lesion, included in the field of irradiation in the late stages[14].

    The above contrastographic features, defined as "ring-like" enhancement, were similarly present in the MRI survey of our population.

    Associated with this aspect is the signal hyperintensity of the treated areas in the acquisitions with T2-weighted and fat saturated T2-weighted sequences, which is also an indicator of radio-induced venoocclusive damage, which in the earliest phases is due to oedema and hyperemia, and with time to fibrosis[15].

    This latter factor is particularly evident in the phenomenon of capsular retraction, present in 64% of cases at the late follow-up.

    All these described elements confirm the data available in the literature on the capability of multiparametric MRI in the evaluation of locoregional hepatic therapy both in terms of post-procedural control and follow-up.

    The use of liver specific contrast agents, based on the functional alteration of the hepatocytes, allows precise delineation of the irradiated field, which will appear hypointense during excretion, with a typical "band" configuration[7,8,16]. This alteration further highlights how radiotherapy-induced structural changes in the liver through veno-venous disease can have a negative impact on the liver's immune system.

    We have also found a direct correlation between the focal hepatic reaction volume calculated by segmentation and the PTV programmed by radiotherapy of the parabolic type.

    The fact that beyond a certain PTV there is not an equal increase in the volume of focal hepatic reaction area could be explained by two factors, one of which is closely linked to the MRI method, which does not allow adequate quantification of the parenchyma. The other explanation could be due to the fibrotic response of the liver: Greater fibrosis in absolute terms results in a greater reduction in liver volume, thus negatively affecting the quantification of the area of hypointensity. According to some authors, this association could be exploited from a clinical-radiotherapeutic point of view both to assess the accuracy of centering and possibly modify it by reducing radio-induced damage, and to quantify "invivo" radiation-induced liver damage and use it as a quantitative biomarker of hepatotoxicity[17-20] .

    Nevertheless, the integration of liver function parameters and MRI-quantifiable liver damage might in the future allow further customised dose delivery or provide additional information to the radiologist in the post-therapeutic evaluation, so as to identify possible biomarkers predictive of liver damage.

    However, this finding, which can be obtained from the earliest post-treatment controls, underlines the technical accuracy of the procedure.

    In our population, no correlation was found between the occurrence of toxicity, the change in blood values, and the radiological findings described.

    The stability of these characteristics of good response to treatment and frequency of infield progression is concomitant with the rise of the frequency curve of outfield progression, which from the 9th month onwards is 9 times more frequent than local progression. This finding could lay a basis for different follow-up timing in patients treated by SBRT.

    It is in fact known that histological changes cause long-term radiological effects, therefore delaying the first follow-up in selected patients beyond the usual 6 mo (all too often not respected) would allow radiologist to express more confidence in the treatment region and at the same time have a greater chance of detecting new liver lesions, thus allowing a better correct staging.

    This study showed the effectiveness of treatment in controlling local disease; indeed, while infield progression decreased from 5% to 3% of the population at subsequent controls, outfield progression tended to increase (from 18% to 28%). However, although it is increasingly used in clinical practice today, the assessment of its effects by MRI is still lacking.

    Limitations of this work are undoubtedly its retrospective nature. This leads both to a lack of systematic planning of the diagnostic procedure of the patients, which sometimes results in an incorrect and non-standardised timing, and to a low population size, since many patients, especially in the follow-ups after the first one, undergo CT scans. Moreover, given the highly differentiated indications, patients undergoing SBRT are a particularly heterogeneous population including individuals with very different lesion sizes and stages. It is therefore clear that this does not allow an indication of the impact of the treatment on survival.

    In addition, as a treatment is particularly effective in controlling local disease, it is not possible to create two comparative subpopulations in order to identify any prognostic or predictive indicators of response to treatment.

    CONCLUSlON

    In conclusion, our study emphasized the role of liver MRI after SBRT for HCC: A multiparametric approach using a liver specific contrast agent provides more information about lesion and liver parenchyma changes compared to conventional CT studies. The direct correlation between the area of hypointensity in the hepatobiliary phase and the PTV is indicative of the accuracy of the radiotherapy treatment and useful to define the infield and outfield progression of the disease.

    Figure 13 Hepatocellular carcinoma in a 75-year-old man treated with stereotactic body radiation therapy. A and B: Diffusion-weighted imaging signal of a lesion located in segment VII, before and after treatment. In the pre-therapy evaluation, the nodule presented a marked narrowing of the diffusion of water molecules, a feature no longer present at post-stereotactic body radiation therapy (SBRT) examination; C: Hepatocellular carcinoma nodule located in segment VII characterized by intermediate signal on T2-weighted imaging; D and E: Initial capsular retraction (white arrow) was already evident at the first post-SBRT magnetic resonance examination and particularly evident at the 9 mo follow-up; F and G: SBRT outcomes characterised by an area of "band" hypodensity in the hepatic excretion phase in the axial and coronal sequences, corresponding to shaded hyperintensity in the T2-weighted sequences with the same distribution and morphology; H: These findings are an expression of treatment-induced fibrosis as demonstrated by the histological finding, where postradiotherapy fibrotic tissue can be identified after liver transplantation.

    ARTlCLE HlGHLlGHTS

    Research background

    Although stereotactic body radiation therapy (SBRT) is increasingly used, its application has not yet been regulated by the main international guidelines, leaving the decision to multidisciplinary teams.

    Research motivation

    Literature is lacking in works assessing the role of liver magnetic resonance imaging (MRI) in the evaluation of hepatocellular carcinoma (HCC) treated by SBRT.

    Research objectives

    To analyse MRI features of HCC lesions treated by SBRT and monitor how these properties evolve over time and how these aspects may modify subsequent diagnostic course of therapy.

    Research methods

    A retrospective observational study was conducted in 49 patients (mean age 64.44 years, range 48.71-84.51), 22 females and 27 males, undergoing radiotherapy between January 2013 and November 2019.

    Research results

    The most significant results came from the evaluation of infield and outfield progression. The risk increased as time progressed, with a sharp increase in the cumulative outfield progression hazard of around 9 after the end of therapy, as shown by the Kaplan-Meier curve study.

    Research conclusions

    A multiparametric approach using a liver specific contrast agent provides more information about lesion and liver parenchyma changes compared to conventional computed tomography studies. The direct correlation between the area of hypointensity in the hepatobiliary phase and the PTV is useful to define the infield and outfield progression of the disease.

    Research perspectives

    Future studies should enlarge the sample of patients and perform further follow-ups for the patients who have already undergone the first two checks.

    FOOTNOTES

    Author contributions:All authors equally contributed to this paper with conception and design of the study, literature review and analysis, manuscript drafting, critical revision, and editing, and approval of the final version.

    lnstitutional review board statement:This retrospective observational study was previously approved by the Intercompany Ethics Committee of the City of Health and Science of Turin.

    lnformed consent statement:Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.

    Conflict-of-interest statement:All the authors are aware of the content of the manuscript and have no conflict of interest to disclose.

    Data sharing statement:Technical appendix, statistical code, and dataset available from the corresponding author at riccardoin@hotmail.it. Consent was not obtained but the presented data are anonymized and risk of identification is low.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:Italy

    ORClD number:Alessandro Serafini 0000-0002-4992-4824; Valeria Ruggeri 0000-0002-3231-0754; Riccardo Inchingolo 0000-0002-0253-5936; Marco Gatti 0000-0001-8168-5280; Alessia Guarneri 0000-0003-1711-3645; Cesare Maino 0000-0002-5742-802X; Davide Ippolito 0000-0002-2696-7047; Luigi Grazioli 0000-0002-2345-1571; Umberto Ricardi 0000-0003-4406-7621; Riccardo Faletti 0000-0002-8865-8637.

    S-Editor:Wang LL

    L-Editor:Wang TQ

    P-Editor:Cai YX

    中文字幕久久专区| 欧美日韩福利视频一区二区| 中国美女看黄片| 久久香蕉国产精品| 一二三四社区在线视频社区8| 久久亚洲精品不卡| 国产精品av视频在线免费观看| 最近视频中文字幕2019在线8| 91国产中文字幕| 一卡2卡三卡四卡精品乱码亚洲| 亚洲国产中文字幕在线视频| 亚洲va日本ⅴa欧美va伊人久久| 一二三四在线观看免费中文在| 国产亚洲精品久久久久久毛片| 男人舔女人下体高潮全视频| 久久久水蜜桃国产精品网| 男人的好看免费观看在线视频 | 少妇粗大呻吟视频| 黄色视频不卡| 色精品久久人妻99蜜桃| 成人亚洲精品av一区二区| 一本综合久久免费| 搡老岳熟女国产| 成在线人永久免费视频| av片东京热男人的天堂| netflix在线观看网站| 精品电影一区二区在线| 久久精品综合一区二区三区| 久久久久性生活片| 国产成+人综合+亚洲专区| 日韩精品青青久久久久久| 国产av不卡久久| 午夜福利视频1000在线观看| 怎么达到女性高潮| 大型黄色视频在线免费观看| 中文字幕熟女人妻在线| 国产成人欧美在线观看| 国产亚洲精品一区二区www| 97碰自拍视频| 亚洲九九香蕉| 国产v大片淫在线免费观看| 国产伦一二天堂av在线观看| 国产亚洲精品第一综合不卡| 舔av片在线| av福利片在线| 真人做人爱边吃奶动态| 又粗又爽又猛毛片免费看| 床上黄色一级片| 麻豆国产av国片精品| 伦理电影免费视频| 精品国产亚洲在线| 国产黄a三级三级三级人| 精品欧美国产一区二区三| 国产精品一区二区免费欧美| 久久婷婷成人综合色麻豆| 国产成年人精品一区二区| 一本久久中文字幕| 国产精品一区二区免费欧美| 亚洲av成人不卡在线观看播放网| 国产精品自产拍在线观看55亚洲| 少妇的丰满在线观看| 国产精品亚洲美女久久久| 亚洲精品一区av在线观看| 中文字幕熟女人妻在线| 99久久综合精品五月天人人| 国产精品1区2区在线观看.| av欧美777| 日本 欧美在线| 亚洲国产精品久久男人天堂| 久久香蕉精品热| 99热只有精品国产| 亚洲成人久久爱视频| 国产激情偷乱视频一区二区| av中文乱码字幕在线| 国产精品精品国产色婷婷| 热99re8久久精品国产| 一区二区三区国产精品乱码| 日韩欧美精品v在线| 一个人免费在线观看电影 | 又黄又粗又硬又大视频| 国产成人系列免费观看| 精品久久久久久久末码| 欧美一级a爱片免费观看看 | 法律面前人人平等表现在哪些方面| 曰老女人黄片| 国产亚洲欧美在线一区二区| 女人被狂操c到高潮| 搞女人的毛片| 免费av毛片视频| 这个男人来自地球电影免费观看| 国产探花在线观看一区二区| 免费看a级黄色片| 一夜夜www| 成人亚洲精品av一区二区| 婷婷精品国产亚洲av| 91麻豆精品激情在线观看国产| 高清毛片免费观看视频网站| 中文字幕高清在线视频| 五月伊人婷婷丁香| 中亚洲国语对白在线视频| 久久午夜综合久久蜜桃| 亚洲全国av大片| 国产精品爽爽va在线观看网站| 日本撒尿小便嘘嘘汇集6| 国产午夜精品论理片| 亚洲国产精品999在线| cao死你这个sao货| 91老司机精品| 国产亚洲精品第一综合不卡| 欧美日韩乱码在线| 国产人伦9x9x在线观看| 嫩草影视91久久| 国产精品精品国产色婷婷| 亚洲欧美精品综合久久99| 激情在线观看视频在线高清| 久久久水蜜桃国产精品网| 久久久精品国产亚洲av高清涩受| 老司机在亚洲福利影院| 久久久久久久久久黄片| 欧美色欧美亚洲另类二区| www日本在线高清视频| avwww免费| 在线观看午夜福利视频| 亚洲av片天天在线观看| 欧美在线黄色| 制服诱惑二区| 黑人操中国人逼视频| 久久久久亚洲av毛片大全| 免费观看人在逋| 校园春色视频在线观看| 一二三四在线观看免费中文在| 天堂动漫精品| 亚洲欧美精品综合久久99| 亚洲专区国产一区二区| 亚洲av日韩精品久久久久久密| 亚洲成a人片在线一区二区| 欧美日韩瑟瑟在线播放| 亚洲熟妇中文字幕五十中出| 女人被狂操c到高潮| 国语自产精品视频在线第100页| 免费电影在线观看免费观看| 亚洲欧美激情综合另类| 国产精品免费视频内射| 久久久国产精品麻豆| 国产精品亚洲av一区麻豆| 成年版毛片免费区| 国产欧美日韩精品亚洲av| 三级毛片av免费| 一本大道久久a久久精品| 日韩精品免费视频一区二区三区| 最近在线观看免费完整版| 午夜日韩欧美国产| 亚洲国产看品久久| 亚洲欧美日韩高清专用| 久久久久免费精品人妻一区二区| 一区福利在线观看| bbb黄色大片| 国内精品一区二区在线观看| 亚洲熟妇熟女久久| 欧美另类亚洲清纯唯美| www.自偷自拍.com| 欧美成人一区二区免费高清观看 | 黄色 视频免费看| 国产亚洲欧美在线一区二区| 正在播放国产对白刺激| 少妇粗大呻吟视频| 久久久久久久精品吃奶| 一级毛片精品| 女人高潮潮喷娇喘18禁视频| 香蕉国产在线看| 亚洲av成人一区二区三| 午夜免费观看网址| 日本撒尿小便嘘嘘汇集6| 777久久人妻少妇嫩草av网站| 欧美黑人欧美精品刺激| 桃色一区二区三区在线观看| 日本黄色视频三级网站网址| 国产精品自产拍在线观看55亚洲| 精品久久久久久久久久免费视频| 国产精品久久久av美女十八| 午夜精品久久久久久毛片777| 亚洲国产欧美网| 国产不卡一卡二| 给我免费播放毛片高清在线观看| 99国产精品一区二区三区| 黄色女人牲交| 亚洲成a人片在线一区二区| 久久国产精品影院| 久久精品综合一区二区三区| 最新美女视频免费是黄的| 伊人久久大香线蕉亚洲五| 亚洲aⅴ乱码一区二区在线播放 | 我要搜黄色片| 脱女人内裤的视频| 婷婷精品国产亚洲av在线| 90打野战视频偷拍视频| 午夜精品在线福利| 淫妇啪啪啪对白视频| 又黄又爽又免费观看的视频| www.自偷自拍.com| 国产高清视频在线观看网站| 国产精品1区2区在线观看.| 亚洲美女黄片视频| 中文字幕人妻丝袜一区二区| 一边摸一边抽搐一进一小说| 亚洲欧美精品综合久久99| 少妇熟女aⅴ在线视频| 亚洲成人精品中文字幕电影| 国产伦人伦偷精品视频| 久久精品国产亚洲av香蕉五月| 国产精品国产高清国产av| 久久99热这里只有精品18| 香蕉国产在线看| 国内精品久久久久精免费| 亚洲真实伦在线观看| 日本 欧美在线| 窝窝影院91人妻| 2021天堂中文幕一二区在线观| 国产精品久久久久久人妻精品电影| 精品欧美一区二区三区在线| 欧美绝顶高潮抽搐喷水| 日韩欧美精品v在线| 麻豆国产97在线/欧美 | 国产探花在线观看一区二区| 久久国产乱子伦精品免费另类| av视频在线观看入口| 精品第一国产精品| 亚洲专区国产一区二区| 国产av在哪里看| 国产高清有码在线观看视频 | 一区二区三区国产精品乱码| 国产精品久久久av美女十八| 国产精品精品国产色婷婷| 夜夜夜夜夜久久久久| 日本熟妇午夜| www.999成人在线观看| 欧美色视频一区免费| 亚洲中文日韩欧美视频| 久久亚洲精品不卡| 可以在线观看的亚洲视频| 少妇熟女aⅴ在线视频| 18禁黄网站禁片免费观看直播| 啪啪无遮挡十八禁网站| 最新美女视频免费是黄的| 欧美激情久久久久久爽电影| 久久精品国产清高在天天线| 真人一进一出gif抽搐免费| 欧美乱码精品一区二区三区| 少妇被粗大的猛进出69影院| 久久精品91无色码中文字幕| 日韩大尺度精品在线看网址| 亚洲 国产 在线| videosex国产| 99久久国产精品久久久| 国产探花在线观看一区二区| 欧美日韩黄片免| 91麻豆精品激情在线观看国产| 大型av网站在线播放| 精品久久蜜臀av无| 亚洲欧美日韩东京热| av中文乱码字幕在线| av在线天堂中文字幕| 国产97色在线日韩免费| 一级毛片高清免费大全| 又粗又爽又猛毛片免费看| 舔av片在线| 免费在线观看成人毛片| 欧美日韩国产亚洲二区| www日本黄色视频网| 狠狠狠狠99中文字幕| 精品久久久久久成人av| 97碰自拍视频| 可以在线观看的亚洲视频| 国产亚洲精品久久久久久毛片| 久久精品国产亚洲av高清一级| 一本精品99久久精品77| 草草在线视频免费看| aaaaa片日本免费| 久久精品91蜜桃| 久久久久久久精品吃奶| 757午夜福利合集在线观看| 亚洲av电影在线进入| 欧美久久黑人一区二区| 欧美午夜高清在线| 欧洲精品卡2卡3卡4卡5卡区| 欧美在线黄色| 夜夜夜夜夜久久久久| 国产爱豆传媒在线观看 | 日韩精品青青久久久久久| 久久九九热精品免费| 国内精品一区二区在线观看| 极品教师在线免费播放| 在线国产一区二区在线| 女生性感内裤真人,穿戴方法视频| 伦理电影免费视频| 丰满的人妻完整版| 校园春色视频在线观看| 国产又色又爽无遮挡免费看| 成人亚洲精品av一区二区| 欧美日本亚洲视频在线播放| 一进一出抽搐动态| 成人av一区二区三区在线看| 一本一本综合久久| 麻豆久久精品国产亚洲av| 亚洲精品久久国产高清桃花| av福利片在线观看| 一个人观看的视频www高清免费观看 | 91麻豆精品激情在线观看国产| 校园春色视频在线观看| 美女大奶头视频| 久久久精品国产亚洲av高清涩受| 国产三级中文精品| 国产av又大| 熟女电影av网| 在线观看免费日韩欧美大片| 亚洲中文字幕日韩| 18禁裸乳无遮挡免费网站照片| 亚洲国产精品合色在线| 69av精品久久久久久| 国产亚洲精品一区二区www| 午夜福利免费观看在线| 天堂av国产一区二区熟女人妻 | 亚洲国产中文字幕在线视频| 国内揄拍国产精品人妻在线| 成人亚洲精品av一区二区| 少妇人妻一区二区三区视频| 欧美黄色淫秽网站| 精品久久久久久,| 日本撒尿小便嘘嘘汇集6| 又粗又爽又猛毛片免费看| 一级作爱视频免费观看| 不卡一级毛片| 午夜福利视频1000在线观看| 国产亚洲精品久久久久久毛片| 最近最新免费中文字幕在线| 欧美日韩精品网址| 久久精品91无色码中文字幕| 女同久久另类99精品国产91| 久久久久国内视频| 国产精品久久久久久久电影 | 国产成人精品无人区| 好看av亚洲va欧美ⅴa在| a级毛片a级免费在线| 99精品在免费线老司机午夜| 午夜影院日韩av| 亚洲色图 男人天堂 中文字幕| 国产精品一区二区三区四区免费观看 | 法律面前人人平等表现在哪些方面| 国内少妇人妻偷人精品xxx网站 | 好男人在线观看高清免费视频| 欧美乱码精品一区二区三区| 国产欧美日韩一区二区三| 制服诱惑二区| 韩国av一区二区三区四区| 午夜日韩欧美国产| 搡老熟女国产l中国老女人| 免费高清视频大片| 欧洲精品卡2卡3卡4卡5卡区| 男女午夜视频在线观看| 欧美乱妇无乱码| 成人高潮视频无遮挡免费网站| 亚洲国产欧美人成| 女人被狂操c到高潮| 熟女电影av网| 亚洲五月天丁香| 看免费av毛片| 国产欧美日韩一区二区三| 又爽又黄无遮挡网站| 国产三级中文精品| 一本久久中文字幕| 亚洲va日本ⅴa欧美va伊人久久| 哪里可以看免费的av片| 国产精品久久电影中文字幕| 久久亚洲精品不卡| 最近在线观看免费完整版| 欧美精品啪啪一区二区三区| 久久香蕉国产精品| 级片在线观看| 亚洲成人精品中文字幕电影| 热99re8久久精品国产| 亚洲一区中文字幕在线| 免费电影在线观看免费观看| 亚洲第一电影网av| 五月伊人婷婷丁香| 国产区一区二久久| 日韩中文字幕欧美一区二区| 最近最新中文字幕大全免费视频| 日日夜夜操网爽| 国产av一区二区精品久久| bbb黄色大片| 婷婷精品国产亚洲av| 国内毛片毛片毛片毛片毛片| 免费在线观看日本一区| 国产主播在线观看一区二区| 97超级碰碰碰精品色视频在线观看| 亚洲 欧美 日韩 在线 免费| 性色av乱码一区二区三区2| 怎么达到女性高潮| 久久精品国产亚洲av香蕉五月| 成年免费大片在线观看| 身体一侧抽搐| 久久精品91无色码中文字幕| 欧美绝顶高潮抽搐喷水| 国产亚洲欧美在线一区二区| 国产又黄又爽又无遮挡在线| 女人高潮潮喷娇喘18禁视频| 国产欧美日韩一区二区精品| 国语自产精品视频在线第100页| 国产精品av久久久久免费| 怎么达到女性高潮| 国产精品久久久久久精品电影| 欧美3d第一页| 99久久久亚洲精品蜜臀av| 91国产中文字幕| 在线观看66精品国产| 91av网站免费观看| 亚洲精品国产一区二区精华液| 首页视频小说图片口味搜索| 全区人妻精品视频| 极品教师在线免费播放| 一级毛片女人18水好多| 草草在线视频免费看| 特大巨黑吊av在线直播| 每晚都被弄得嗷嗷叫到高潮| 这个男人来自地球电影免费观看| 国产精品1区2区在线观看.| а√天堂www在线а√下载| 亚洲自偷自拍图片 自拍| 琪琪午夜伦伦电影理论片6080| 在线播放国产精品三级| 国产成人系列免费观看| cao死你这个sao货| 亚洲精华国产精华精| 中文资源天堂在线| 88av欧美| 中文在线观看免费www的网站 | 美女大奶头视频| 国产97色在线日韩免费| 男人舔奶头视频| 一级作爱视频免费观看| 免费在线观看影片大全网站| 成年人黄色毛片网站| 久久国产精品影院| 一边摸一边抽搐一进一小说| 亚洲色图av天堂| 在线观看美女被高潮喷水网站 | 欧美性长视频在线观看| 久久久久久国产a免费观看| 黑人操中国人逼视频| 欧美zozozo另类| 麻豆成人av在线观看| 国产熟女午夜一区二区三区| 午夜福利18| 午夜成年电影在线免费观看| 日本精品一区二区三区蜜桃| 看黄色毛片网站| 亚洲七黄色美女视频| 国产精品免费视频内射| 99精品久久久久人妻精品| 人人妻,人人澡人人爽秒播| www国产在线视频色| 欧美黑人精品巨大| 亚洲欧美日韩高清在线视频| 叶爱在线成人免费视频播放| 一二三四在线观看免费中文在| tocl精华| 亚洲真实伦在线观看| 国产激情久久老熟女| 久久中文看片网| 波多野结衣巨乳人妻| 久久精品国产亚洲av高清一级| 在线观看免费视频日本深夜| 三级毛片av免费| 国产一区在线观看成人免费| 观看免费一级毛片| 嫩草影院精品99| 老司机在亚洲福利影院| 午夜精品久久久久久毛片777| 亚洲乱码一区二区免费版| 亚洲avbb在线观看| 男女床上黄色一级片免费看| 香蕉久久夜色| a在线观看视频网站| 999久久久国产精品视频| 少妇的丰满在线观看| 亚洲成人国产一区在线观看| 男男h啪啪无遮挡| 欧美zozozo另类| 不卡一级毛片| 欧美3d第一页| 99热只有精品国产| 亚洲一区二区三区不卡视频| 麻豆av在线久日| 日本免费一区二区三区高清不卡| 人妻久久中文字幕网| 丰满人妻一区二区三区视频av | e午夜精品久久久久久久| 午夜a级毛片| 国产探花在线观看一区二区| а√天堂www在线а√下载| 亚洲 欧美 日韩 在线 免费| 久久久久久亚洲精品国产蜜桃av| 91麻豆精品激情在线观看国产| 一区二区三区国产精品乱码| 母亲3免费完整高清在线观看| 日本黄色视频三级网站网址| 最新在线观看一区二区三区| 午夜免费观看网址| 在线观看舔阴道视频| 亚洲精华国产精华精| 日韩免费av在线播放| 亚洲av电影不卡..在线观看| 日韩三级视频一区二区三区| 欧美激情久久久久久爽电影| av福利片在线| 亚洲片人在线观看| 国产激情欧美一区二区| cao死你这个sao货| 日韩免费av在线播放| 一卡2卡三卡四卡精品乱码亚洲| 亚洲av成人av| 欧美乱色亚洲激情| tocl精华| 日韩 欧美 亚洲 中文字幕| 免费观看精品视频网站| 精品免费久久久久久久清纯| 亚洲中文字幕一区二区三区有码在线看 | 国产成人一区二区三区免费视频网站| 久久精品aⅴ一区二区三区四区| 国产精品野战在线观看| 男女视频在线观看网站免费 | 午夜福利成人在线免费观看| 19禁男女啪啪无遮挡网站| 色老头精品视频在线观看| 别揉我奶头~嗯~啊~动态视频| 国产在线观看jvid| 脱女人内裤的视频| 国产精品久久久久久人妻精品电影| 欧美一区二区精品小视频在线| 亚洲欧美精品综合久久99| АⅤ资源中文在线天堂| 老熟妇乱子伦视频在线观看| 狂野欧美白嫩少妇大欣赏| 国内揄拍国产精品人妻在线| 精品第一国产精品| 男女之事视频高清在线观看| 老司机靠b影院| 亚洲av电影不卡..在线观看| 琪琪午夜伦伦电影理论片6080| 国产精品1区2区在线观看.| 精品一区二区三区四区五区乱码| 在线永久观看黄色视频| 香蕉久久夜色| 久久精品成人免费网站| 欧美日韩黄片免| 久久久精品国产亚洲av高清涩受| 欧美av亚洲av综合av国产av| 久久伊人香网站| 欧美黑人欧美精品刺激| 亚洲av中文字字幕乱码综合| 美女午夜性视频免费| 亚洲精品国产一区二区精华液| av欧美777| 久久久久久久久免费视频了| 国产黄a三级三级三级人| 国产熟女xx| 国产精品av久久久久免费| 欧美不卡视频在线免费观看 | 777久久人妻少妇嫩草av网站| 中国美女看黄片| 黄色 视频免费看| 中文字幕精品亚洲无线码一区| 日韩欧美精品v在线| 法律面前人人平等表现在哪些方面| 免费电影在线观看免费观看| 免费观看精品视频网站| 亚洲av电影在线进入| 成人高潮视频无遮挡免费网站| 久久精品91无色码中文字幕| 身体一侧抽搐| 国产日本99.免费观看| 日韩 欧美 亚洲 中文字幕| 亚洲天堂国产精品一区在线| 亚洲精品美女久久av网站| 搡老熟女国产l中国老女人| 色播亚洲综合网| 妹子高潮喷水视频| 很黄的视频免费| 久久精品夜夜夜夜夜久久蜜豆 | 日韩欧美 国产精品| 桃色一区二区三区在线观看| 久久精品aⅴ一区二区三区四区| 国产成人av激情在线播放| 色综合站精品国产| 99国产精品一区二区三区| 丝袜人妻中文字幕| 老司机靠b影院| 国产精品亚洲av一区麻豆| 18禁国产床啪视频网站| 少妇熟女aⅴ在线视频| 美女 人体艺术 gogo| 久久天堂一区二区三区四区| 日韩国内少妇激情av| 欧美日韩一级在线毛片| 色综合亚洲欧美另类图片| 两性午夜刺激爽爽歪歪视频在线观看 | 国产精品国产高清国产av| 99热6这里只有精品| 国产精品一区二区三区四区久久| 国产精品国产高清国产av| 在线看三级毛片| 亚洲精品美女久久av网站| 国产亚洲av高清不卡| 色av中文字幕| 中文字幕熟女人妻在线|